| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,509 |
10,156 |
$999K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,054 |
896 |
$355K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,145 |
982 |
$97K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,093 |
3,553 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,842 |
1,624 |
$92K |
| 36410 |
|
4,229 |
3,475 |
$63K |
| 87581 |
|
1,044 |
907 |
$43K |
| 87486 |
|
1,044 |
907 |
$43K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
389 |
345 |
$33K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
450 |
379 |
$18K |
| 99386 |
|
142 |
131 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
238 |
218 |
$12K |
| 99490 |
Ccm add 20min |
1,016 |
1,007 |
$11K |
| 96127 |
|
748 |
582 |
$11K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
107 |
97 |
$9K |
| 81000 |
|
2,836 |
2,328 |
$8K |
| 99385 |
|
72 |
65 |
$7K |
| 86769 |
|
152 |
138 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
367 |
294 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
103 |
90 |
$5K |
| 93923 |
|
62 |
62 |
$3K |
| 99439 |
|
326 |
318 |
$3K |
| 99215 |
Prolong outpt/office vis |
53 |
52 |
$3K |
| 99397 |
|
32 |
27 |
$3K |
| 99205 |
Prolong outpt/office vis |
24 |
23 |
$2K |
| 95923 |
|
54 |
49 |
$2K |
| 95921 |
|
53 |
48 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
207 |
175 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
57 |
52 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
41 |
13 |
$2K |
| 93000 |
|
119 |
90 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
66 |
60 |
$1K |
| 96368 |
|
41 |
13 |
$748.66 |
| 99457 |
|
144 |
139 |
$520.66 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
41 |
13 |
$469.86 |
| 99454 |
|
175 |
172 |
$349.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
20 |
17 |
$42.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
80 |
26 |
$14.70 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
71 |
66 |
$9.10 |
| 99453 |
|
13 |
13 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$0.00 |